Detection of submicroscopic disease in the bone marrow and unaffected testis of a child with T-cell acute lymphoblastic leukemia who experienced "isolated" testicular relapse.
Testicular relapse has an impact on the prognosis of boys with acute lymphoblastic leukemia (ALL). Because isolated testicular relapse often precedes hematological relapse, systemic therapy is required in addition to local therapy. However, a rationale for the use of a combination of systemic chemotherapy and local therapy is unclear. A 12-year-old boy with T-ALL suffered from isolated testicular relapse at 27 months after diagnosis. He was successfully treated with systemic chemotherapy with orchiectomy and prophylactic irradiation to the contralateral testis. We retrospectively estimated the minimal residual disease in the bone marrow (BM) and the testis by detection of clone-specific T-cell receptor rearrangement of leukemic cells. We detected leukemic cells in the affected testis at relapse, as well as in the BM at initial diagnosis. In addition, we confirmed submicroscopic disease in the unaffected testis and the BM at relapse. We conclude that molecular analysis could reveal the submicroscopic disease in the patient with apparently isolated testicular relapse. This finding may provide a rationale for intensified systemic treatment of patients with isolated testicular relapse.
Arima
Keitaro
K
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
Hasegawa
Daisuke
D
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan. hase-dai@umin.net.
Ogawa
Chitose
C
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
Kato
Itaru
I
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
Imamura
Toshihiro
T
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
Takusagawa
Ayako
A
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
Takahashi
Hiroka
H
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
Kitagawa
Yoshiro
Y
Department of Pediatrics, Aichi Medical University, Aichi, Japan.
Hori
Toshinari
T
Department of Pediatrics, Aichi Medical University, Aichi, Japan.
Tsurusawa
Masahito
M
Department of Pediatrics, Aichi Medical University, Aichi, Japan.
Manabe
Atsushi
A
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
Hosoya
Ryota
R
Department of Pediatrics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D002648:Child; D003131:Combined Modality Therapy; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D018365:Neoplasm, Residual / Q000473:pathology; D009919:Orchiectomy; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology*; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D013737:Testis / Q000473:pathology* / Q000601:surgery; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin
Urology. 1980 Oct;16(4):370-4
6932135
Br J Haematol. 1998 Sep;102(4):1050-4
9734657
Ann Hematol. 1991 Apr;62(4):108-14
2031973
Leukemia. 1999 Jan;13(1):110-8
10049045
Leukemia. 2000 Dec;14(12):2193-4
11187910
J Clin Oncol. 1999 Mar;17(3):818-24
10071272
Leukemia. 1998 Jul;12(7):1081-8
9665194
J Clin Oncol. 2005 May 1;23(13):3038-42
15860861
Cancer. 1998 Apr 1;82(7):1387-95
9529033
N Engl J Med. 2006 Jan 12;354(2):166-78
16407512
J Clin Oncol. 2005 Nov 1;23(31):7942-50
16258094
Blood. 1990 Mar 1;75(5):1051-5
2407298
Cancer. 1986 Sep 1;58(5):1024-8
3524797
Blood. 1991 Jan 15;77(2):331-9
1824678
J Clin Oncol. 1984 Aug;2(8):924-9
6589364
Haematologica. 2008 Aug;93(8):1155-60
18519521
Blood. 2007 Dec 1;110(12):4022-9
17720883
Mol Pathol. 1998 Oct;51(5):277-81
10193523
World J Urol. 1995;13(4):230-2
8528297